Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

OHI--Randomized Control Trial to Evaluate Efficacy, Acceptability, and Perception of Benefit of an Innovative Custom AFO

NCT02819011 is registered in ClinicalTrials.gov with Bijan Najafi, PhD as lead sponsor.

NCT NCT02819011
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02819011 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
OHI--Randomized Control Trial to Evaluate Efficacy, Acceptability, and Perception of Benefit of an Innovative Custom AFO
Lead sponsor
Bijan Najafi, PhD
Phase
Phase 2
Overall status
Completed
Start date
May 31, 2016
Completion date
April 4, 2019
Enrollment
44 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

accidental falls, arthritis, cancer, diabetes, end stage renal failure on dialysis, fall due to loss of equilibrium, high risk of falls due to mobility limitation, parkinson's disease, peripheral arterial disease